Browsing by Author "Elshafei, Mohamed Nabil"
Now showing items 1-10 of 10
-
Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis
Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; Abubeker, Ibrahim Y.; Mohamed, Mouhand F.H.... more authors ... less authors ( Wiley-Blackwell , 2021 , Article)Background: Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients. ... -
Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis
Elshafei, Mohamed Nabil; Mohamed, Mouhand F.H.; El-Bardissy, Ahmed; Ahmed, Mohamed Badie; Abdallah, Ibtihal; Elewa, Hazem; Danjuma, Mohammed... more authors ... less authors ( Springer , 2021 , Article)Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice. However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly obese patients (bodyweight of > 120 kg or ... -
Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight
Danjuma, Mohammed Ibn Mas ud; Elshafei, Mohamed Nabil; Al-Khal, Noof Abdulrahman; Mohamed, Mouhand Faisal Hamad ( Wiley-Blackwell , 2022 , Other)Bodega et al.'s recent report on the efficacy and safety of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation and extreme body weight reinforces recent therapeutics advances in anticoagulation ... -
The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study. A letter to the Editor
Mohammed I., Danjuma; Al-Khulaifi, Azhar; Elshafei, Mohamed Nabil ( Elsevier , 2022 , Other)We read with interest Bij de Weg et al.’s, recent mechanistic report on the inhibitory effect of Aspirin on platelet function in patients with pre-eclampsia [1]. Compared to placebo, this study found that 80 mg of generic ... -
Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes: A protocol for systematic review of randomised controlled clinical trials utilising a generalised pairwise modelling methodology.
Danjuma, Mohammed Ibn-Mas'ud; Shokri, Shaikha Al; Saud, Arwa Ibrahim Ya Al; Elshafei, Mohamed Nabil Abdelsalam; Fatima, Haajra; Doi, Suhail; Bidmos, Mubarak Ariyo... more authors ... less authors ( Wolters Kluwer Health, Inc. , 2019 , Article)Recent systematic reviews have evaluated the efficacy of sodium-glucose co-transporter 2 inhibitors (SGLT2) inhibitors (SGLT2I) in improving glycaemic control and mortality in patients with type II diabetes mellitus. None ... -
The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
Elshafei, Mohamed Nabil; Imam, Yahia; Alsaud, Arwa Ebrahim; Chandra, Prem; Parray, Aijaz; Abdelmoneim, Mohamed S.; Obeidat, Khaldun; Saeid, Razan; Ali, Mohammad; Ayadathil, Raheem; Mohamed, Mouhand F.H.; Abdallah, Ibtihal M.; Mohammed, Shaban; Akhtar, Naveed; Danjuma, Mohammed Ibn Masoud... more authors ... less authors ( Springer Nature , 2022 , Article)Background and purpose: Uncertainty remains regarding the impact of enteric-coated aspirin (EC-ASA) on secondary prevention of ischemic stroke compared to plain aspirin (P-ASA). Hence, this study was designed to investigate ... -
An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)
Elshafei, Mohamed Nabil; Imam, Yahia; Mohamed, Mouhand F.H.; Alsaud, Arwa Ebrahim; Ahmed, Mohamed Sayed; Obeidat, Khaldun; Saeid, Razan; Ali, Mohamed; Abdallah, Ibtihal M.; Parray, Aeijaz Sultan; Danjuma, Mohammed Ibn Masoud... more authors ... less authors ( Wolters Kluwer Health , 2020 , Article)Introduction:Uncertainty remains regarding the impact of enteric-coated (EC) aspirin as it relates to the reduction of cardiovascular risk. We hypothesize that EC formulation based on a previous report may blunt aspirin ... -
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Mohamed, Mouhand F.H.; Al-Shokri, Shaikha D.; Shunnar, Khaled M.; Mohamed, Sara F.; Najim, Mostafa S.; Ibrahim, Shahd I.; Elewa, Hazem; Abdalla, Lina O.; El-Bardissy, Ahmed; Elshafei, Mohamed Nabil; Abubeker, Ibrahim Y.; Danjuma, Mohammed; Dousa, Khalid M.; Yassin, Mohamed A.... more authors ... less authors ( Frontiers Media S.A. , 2021 , Article)Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE) events in coronavirus disease 2019 (COVID-19) patients, especially in those who are critically ill. Available studies report varying ... -
Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review
Y. Elzouki, Abdel Naser; Elshafei, Mohamed Nabil; Aziz, Afia; Elzouki, Islam; Waheed, Muhammad Aamir; Farooqui, Khalid; Azad, Aftab Mohammed; Habas, Elmukhtar; Danjuma, Mohammed I.... more authors ... less authors ( HBKU Press , 2023 , Article)Background and Aims: As part of the COVID-19 control strategy, a growing number of vaccine portfolios evolved and got fast-tracked through regulatory agencies, with a limited examination of their efficacy and safety in ... -
Warfarin-Rifampin-Gene (WARIF-G) Interaction: A Retrospective, Genetic, Case–Control Study
Salem, Muhammad; El-Bardissy, Ahmed; Elshafei, Mohamed Nabil; Khalil, Ahmed; Mahmoud, Hesham; Fahmi, Amr Mohamed; Kasem, Mohamed; Bader, Loulia; Sherbash, Mohamed; Elawady, Mostafa Ibrahim; Abdalazim, Walaa; Howady, Faraj; Elewa, Hazem... more authors ... less authors ( Wiley-Blackwell , 2023 , Article)Warfarin is extensively metabolized by cytochrome P450 2C9 (CYP2C9). Concomitant use with the potent CYP2C9 inducer, rifampin, requires close monitoring and dosage adjustments. Although, in theory, warfarin dose increase ...